Sorrento Therapeutics (SRNEQ) Stock Chart & Stock Price History $0.0020 +0.00 (+33.33%) As of 08/13/2025 Add Compare Share Share Chart Stock AnalysisChartSEC FilingsBuy This Stock Sorrento Therapeutics Stock Price Performance The Sorrento Therapeutics (SRNEQ) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 75.31%, with a year-to-date return of 300.00%. In the past month, the stock has decreased 16.67%, reflecting recent market activity. As of the latest close, Sorrento Therapeutics traded at $0.00 with a market cap of $1.08 million and volume of 18,950 shares. Receive SRNEQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+33.33%1 Month Performance-16.67%3 Month Performance+81.82%Year-To-Date Performance+300.00%1 Year Performance-75.31% SRNEQ Stock Chart for Thursday, August, 14, 2025 SRNEQ Chart by TradingView Sorrento Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$0.00$0.00+2.56%$0.00$0.00528,669 shs$1.10 million08/13/2025$0.00$0.00$0.00$0.0018,950 shs$1.08 million08/12/2025$0.00$0.00+30.00%$0.00$0.0018,950 shs$1.08 million08/11/2025$0.00$0.00$0.00$0.0079,746 shs$827,000.0008/08/2025$0.00$0.00-34.78%$0.00$0.0078,187 shs$827,000.0008/07/2025$0.00$0.00$0.00$0.00100,859 shs$1.27 million08/06/2025$0.00$0.00+53.33%$0.00$0.00100,859 shs$1.27 million08/05/2025$0.00$0.00$0.01$0.0018,428 shs$827,000.0008/04/2025$0.00$0.00$0.00$0.00488,692 shs$827,000.0008/01/2025$0.00$0.00$0.00$0.0097,435 shs$827,000.00 Get the Latest News and Ratings for SRNEQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$0.00$0.00$0.00$0.0097,435 shs$827,000.0007/30/2025$0.00$0.00-40.00%$0.00$0.0097,435 shs$827,000.0007/29/2025$0.00$0.00+78.57%$0.00$0.0051,704 shs$1.38 million07/28/2025$0.00$0.00$0.00$0.0077,181 shs$772,000.0007/25/2025$0.00$0.00$0.00$0.0023,753 shs$717,000.0007/24/2025$0.00$0.00-7.14%$0.01$0.0043,805 shs$717,000.0007/23/2025$0.00$0.00$0.00$0.0091,898 shs$772,000.0007/22/2025$0.00$0.00$0.00$0.0091,898 shs$772,000.0007/21/2025$0.00$0.00$0.00$0.0091,898 shs$772,000.0007/18/2025$0.00$0.00-33.33%$0.01$0.00134,929 shs$882,000.0007/17/2025$0.00$0.00$0.00$0.0078,192 shs$1.32 million07/16/2025$0.00$0.00$0.00$0.0078,192 shs$1.32 million07/15/2025$0.00$0.00$0.00$0.0078,192 shs$1.32 million07/14/2025$0.00$0.00$0.00$0.0078,192 shs$1.32 million Related Companies OTLK Stock Chart RPTX Stock Chart IRD Stock Chart CNTX Stock Chart FBRX Stock Chart IZTC Stock Chart APLT Stock Chart INMB Stock Chart BMEA Stock Chart INKT Stock Chart Receive SRNEQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:SRNEQ) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sorrento Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access